Invention Application
- Patent Title: CELLULAR IMMUNITY INDUCING VACCINE
- Patent Title (中): 细胞免疫诱导疫苗
-
Application No.: US14901384Application Date: 2014-06-30
-
Publication No.: US20160166665A1Publication Date: 2016-06-16
- Inventor: Masaki ITO , Kiyotaka SHIBA
- Applicant: JAPANESE FOUNDATION FOR CANCER RESEARCH , THE JIKEI UNIVERSITY
- Applicant Address: JP Tokyo JP Tokyo
- Assignee: JAPANESE FOUNDATION FOR CANCER RESEARCH,THE JIKEI UNIVERSITY
- Current Assignee: JAPANESE FOUNDATION FOR CANCER RESEARCH,THE JIKEI UNIVERSITY
- Current Assignee Address: JP Tokyo JP Tokyo
- Priority: JP2013-138688 20130702
- International Application: PCT/JP2014/067355 WO 20140630
- Main IPC: A61K39/00
- IPC: A61K39/00

Abstract:
A novel vaccine that can induce sufficiently high cell-mediated immunity is disclosed. The vaccine of the present invention contains, as an effective component, a polypeptide comprising a tandem repeat structure in which an MHC class I epitope region derived from an antigen protein and a spacer sequence are linked to each other alternately and repeatedly at least three times, or a recombinant vector which comprises a polynucleotide encoding said polypeptide and is capable of expressing said polypeptide in vivo. The spacer sequence is, for example, a sequence generated as an amino acid sequence inevitably encoded by a single base sequence which is designed such that the MHC class I epitope region derived from the antigen protein, an MHC class II epitope region derived from the antigen protein, and at least one higher-order-structure-stabilizing region are encoded by different reading frames in said single base sequence.
Public/Granted literature
- US10898555B2 Cellular immunity inducing vaccine Public/Granted day:2021-01-26
Information query